Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)

Study Overview
=================
Brief Summary
-----------------
The non-essential and non-urgent follow-up consultations of patients living with HIV were postponed or transformed into teleconsultation or exchanges of e-mails between practitioners and patients during COVID-19 epidemic. This change in care can have an impact on follow-up and access to treatment for PVVIH.

Detailed Description
-----------------
On 16 March 2020, an instruction to postpone non-urgent consultations was given to doctors. Thus, the non-essential and non-urgent follow-up consultations of patients living with HIV were postponed or transformed into teleconsultation or exchanges of e-mails between practitioners and patients. This change in care can have an impact on follow-up and access to treatment for PVVIH. In addition, the epidemic itself may have consequences: PVVIH may be at greater risk because of their immunosuppression and associated co-morbidities.

Official Title
-----------------
Evaluation of the Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)

Conditions
-----------------
Virus-HIV, Covid19

Intervention / Treatment
-----------------
* Other: questionnaire


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient followed up for HIV infection in one of the COREVIH Hauts de France centres participating in the study Having communicated an email address Having given their consent to participate in this study Beneficiary subject affiliated or entitled to a social security scheme Exclusion Criteria: Minor patient Refusal to participate Patient under guardianship

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Other: experimental arm<br>questionnaire and follow-up visit | Other: questionnaire<br>* bi-monthly questionnaire and then one visit with questionnaire and covid-19 test<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Prevalence of SARS CoV2 infection in PVVIH in Hauts de France | Determination of the number of patients with microbiologically or clinically-biologically proven SARS CoV2 infection at inclusion in the study | Inclusion | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Prevalence of SARS CoV2 infection in PVVIH in Hauts de France | Determination of the number of patients with microbiologically or clinically-biologically proven SARS CoV2 infection at the end of the study | through study completion, an average of 19 months | 
| Determine the incidence rate of COVID 19 among PVVIH antiretroviral treatment | Percentage of patients who stopped their antiretroviral treatment | through study completion, an average of 19 months | 
| Determine the incidence rate of COVID 19 among PVVIH discontinuing antiretroviral treatment | Reason for discontinuing antiretroviral treatment | through study completion, an average of 19 months | 
| Determine the incidence rate of COVID 19 among PVVIH who stopped all follow-up | Percentage of patients who stopped all follow-up by an infectious disease specialist | through study completion, an average of 19 months | 
| Psychological consequences of this epidemic among PVVIH : HAD | Evaluation of the psychological scales HAD on PVVIH | through study completion, an average of 19 months | 
| Psychological consequences of this epidemic among PVVIH : PROQOL-HIV | Evaluation of the psychological scales PROQOL-HIV on PVVIH | through study completion, an average of 19 months |